Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Published Online October 9, 2008
Science DOI: 10.1126/science.1164270

Reports

Submitted on August 6, 2008
Accepted on September 25, 2008

Generation of Mouse Induced Pluripotent Stem Cells Without Viral Vectors

Keisuke Okita 1, Masato Nakagawa 2, Hong Hyenjong 3, Tomoko Ichisaka 4, Shinya Yamanaka 5*

1 Center for iPS Cell Research and Application (CiRA), Institute for Integrated Cell-Material Sciences, Kyoto University, Kyoto 606-8507, Japan.
2 Center for iPS Cell Research and Application (CiRA), Institute for Integrated Cell-Material Sciences, Kyoto University, Kyoto 606-8507, Japan.; Department of Stem Cell Biology, Institute for Frontier Medical Sciences, Kyoto University, Kyoto 606-8507, Japan.
3 Department of Stem Cell Biology, Institute for Frontier Medical Sciences, Kyoto University, Kyoto 606-8507, Japan.
4 Center for iPS Cell Research and Application (CiRA), Institute for Integrated Cell-Material Sciences, Kyoto University, Kyoto 606-8507, Japan.; CREST and Yamanaka iPS Cell Project, Japan Science and Technology Agency, Kawaguchi 332-0012, Japan.
5 Center for iPS Cell Research and Application (CiRA), Institute for Integrated Cell-Material Sciences, Kyoto University, Kyoto 606-8507, Japan.; Department of Stem Cell Biology, Institute for Frontier Medical Sciences, Kyoto University, Kyoto 606-8507, Japan.; CREST and Yamanaka iPS Cell Project, Japan Science and Technology Agency, Kawaguchi 332-0012, Japan.; Gladstone Institute of Cardiovascular Disease, San Francisco, CA 94158, USA.

* To whom correspondence should be addressed.
Shinya Yamanaka , E-mail: yamanaka{at}frontier.kyoto-u.ac.jp

Induced pluripotent stem (iPS) cells have been generated from mouse and human somatic cells by introducing Oct3/4, and Sox2 with either Klf4 and c-Myc or Nanog and Lin28 using retroviruses or lentiviruses. Patient-specific iPS cells could be useful in drug discovery and regenerative medicine. However, viral integration into the host genome increases the risk of tumorigenicity. Here we report the generation of mouse iPS cells without viral vectors. Repeated transfection of a single plasmid containing the cDNAs of Oct3/4, Sox2, and Klf4, together with a c-Myc expression plasmid, into mouse embryonic fibroblasts resulted in iPS cells without evidence of plasmid integration, which produced teratomas when transplanted into mice and contributed to adult chimeras. The production of virus-free iPS cells, albeit from embryonic fibroblasts, addresses a critical safety concern for potential use of iPS cells in regenerative medicine.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells.
C. Li, J. Zhou, G. Shi, Y. Ma, Y. Yang, J. Gu, H. Yu, S. Jin, Z. Wei, F. Chen, et al. (2009)
Hum. Mol. Genet. 18, 4340-4349
   Abstract »    Full Text »    PDF »
Complex architecture and regulated expression of the Sox2ot locus during vertebrate development.
P. P. Amaral, C. Neyt, S. J. Wilkins, M. E. Askarian-Amiri, S. M. Sunkin, A. C. Perkins, and J. S. Mattick (2009)
RNA 15, 2013-2027
   Abstract »    Full Text »    PDF »
Genomic and Expression Profiling of Glioblastoma Stem Cell-Like Spheroid Cultures Identifies Novel Tumor-Relevant Genes Associated with Survival.
A. Ernst, S. Hofmann, R. Ahmadi, N. Becker, A. Korshunov, F. Engel, C. Hartmann, J. Felsberg, M. Sabel, H. Peterziel, et al. (2009)
Clin. Cancer Res. 15, 6541-6550
   Abstract »    Full Text »    PDF »
Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cells.
D. S. Kaufman (2009)
Blood 114, 3513-3523
   Abstract »    Full Text »    PDF »
Cardiomyocyte Differentiation of Human Induced Pluripotent Stem Cells.
L. Zwi, O. Caspi, G. Arbel, I. Huber, A. Gepstein, I.-H. Park, and L. Gepstein (2009)
Circulation 120, 1513-1523
   Abstract »    Full Text »    PDF »
Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells.
J. Utikal, N. Maherali, W. Kulalert, and K. Hochedlinger (2009)
J. Cell Sci. 122, 3502-3510
   Abstract »    Full Text »    PDF »
Cardiac Cell Repair Therapy: A Clinical Perspective.
B. J. Gersh, R. D. Simari, A. Behfar, C. M. Terzic, and A. Terzic (2009)
Mayo Clin. Proc. 84, 876-892
   Abstract »    Full Text »    PDF »
On the Road to iPS Cell Cardiovascular Applications.
T. J. Kamp and G. E. Lyons (2009)
Circ. Res. 105, 617-619
   Full Text »    PDF »
iPS Programmed Without c-MYC Yield Proficient Cardiogenesis for Functional Heart Chimerism.
A. Martinez-Fernandez, T. J. Nelson, S. Yamada, S. Reyes, A. E. Alekseev, C. Perez-Terzic, Y. Ikeda, and A. Terzic (2009)
Circ. Res. 105, 648-656
   Abstract »    Full Text »    PDF »
Generation of pluripotent stem cells from patients with type 1 diabetes.
R. Maehr, S. Chen, M. Snitow, T. Ludwig, L. Yagasaki, R. Goland, R. L. Leibel, and D. A. Melton (2009)
PNAS 106, 15768-15773
   Abstract »    Full Text »    PDF »
Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells.
N. Sun, N. J. Panetta, D. M. Gupta, K. D. Wilson, A. Lee, F. Jia, S. Hu, A. M. Cherry, R. C. Robbins, M. T. Longaker, et al. (2009)
PNAS 106, 15720-15725
   Abstract »    Full Text »    PDF »
Senescence impairs successful reprogramming to pluripotent stem cells.
A. Banito, S. T. Rashid, J. C. Acosta, S. Li, C. F. Pereira, I. Geti, S. Pinho, J. C. Silva, V. Azuara, M. Walsh, et al. (2009)
Genes & Dev. 23, 2134-2139
   Abstract »    Full Text »    PDF »
Emerging potential of transposons for gene therapy and generation of induced pluripotent stem cells.
T. VandenDriessche, Z. Ivics, Z. Izsvak, and M. K. L. Chuah (2009)
Blood 114, 1461-1468
   Abstract »    Full Text »    PDF »
Stoichiometric and temporal requirements of Oct4, Sox2, Klf4, and c-Myc expression for efficient human iPSC induction and differentiation.
E. P. Papapetrou, M. J. Tomishima, S. M. Chambers, Y. Mica, E. Reed, J. Menon, V. Tabar, Q. Mo, L. Studer, and M. Sadelain (2009)
PNAS 106, 12759-12764
   Abstract »    Full Text »    PDF »
Repair of Acute Myocardial Infarction by Human Stemness Factors Induced Pluripotent Stem Cells.
T. J. Nelson, A. Martinez-Fernandez, S. Yamada, C. Perez-Terzic, Y. Ikeda, and A. Terzic (2009)
Circulation 120, 408-416
   Abstract »    Full Text »    PDF »
Derivation of induced pluripotent stem cells from pig somatic cells.
T. Ezashi, B. P. V. L. Telugu, A. P. Alexenko, S. Sachdev, S. Sinha, and R. M. Roberts (2009)
PNAS 106, 10993-10998
   Abstract »    Full Text »    PDF »
Generation of Induced Pluripotent Stem Cell Lines from Tibetan Miniature Pig.
M. A. Esteban, J. Xu, J. Yang, M. Peng, D. Qin, W. Li, Z. Jiang, J. Chen, K. Deng, M. Zhong, et al. (2009)
J. Biol. Chem. 284, 17634-17640
   Abstract »    Full Text »    PDF »
Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases.
L. Ye, J. C. Chang, C. Lin, X. Sun, J. Yu, and Y. W. Kan (2009)
PNAS 106, 9826-9830
   Abstract »    Full Text »    PDF »
Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4.
C. A. Lyssiotis, R. K. Foreman, J. Staerk, M. Garcia, D. Mathur, S. Markoulaki, J. Hanna, L. L. Lairson, B. D. Charette, L. C. Bouchez, et al. (2009)
PNAS 106, 8912-8917
   Abstract »    Full Text »    PDF »
Generation of mouse-induced pluripotent stem cells by transient expression of a single nonviral polycistronic vector.
F. Gonzalez, M. Barragan Monasterio, G. Tiscornia, N. Montserrat Pulido, R. Vassena, L. Batlle Morera, I. Rodriguez Piza, and J. C. I. Belmonte (2009)
PNAS 106, 8918-8922
   Abstract »    Full Text »    PDF »
Cellular reprogramming and pluripotency induction.
M. W. Lensch (2009)
Br. Med. Bull. 90, 19-35
   Abstract »    Full Text »    PDF »
Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences.
J. Yu, K. Hu, K. Smuga-Otto, S. Tian, R. Stewart, I. I. Slukvin, and J. A. Thomson (2009)
Science 324, 797-801
   Abstract »    Full Text »    PDF »
Instructing an Embryonic Stem Cell-Derived Oocyte Fate: Lessons from Endogenous Oogenesis.
C. R. Nicholas, S. L. Chavez, V. L. Baker, and R. A. Reijo Pera (2009)
Endocr. Rev. 30, 264-283
   Abstract »    Full Text »    PDF »
Unique and Overlapping Functions of GSK-3 Isoforms in Cell Differentiation and Proliferation and Cardiovascular Development.
T. Force and J. R. Woodgett (2009)
J. Biol. Chem. 284, 9643-9647
   Abstract »    Full Text »    PDF »
Klf4 reverts developmentally programmed restriction of ground state pluripotency.
G. Guo, J. Yang, J. Nichols, J. S. Hall, I. Eyres, W. Mansfield, and A. Smith (2009)
Development 136, 1063-1069
   Abstract »    Full Text »    PDF »
Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells.
J. Zhang, G. F. Wilson, A. G. Soerens, C. H. Koonce, J. Yu, S. P. Palecek, J. A. Thomson, and T. J. Kamp (2009)
Circ. Res. 104, e30-e41
   Abstract »    Full Text »    PDF »
Epigenetic reprogramming and induced pluripotency.
K. Hochedlinger and K. Plath (2009)
Development 136, 509-523
   Abstract »    Full Text »    PDF »
Triggering the regeneration and tissue repair programs.
E. Tanaka and B. Galliot (2009)
Development 136, 349-353
   Abstract »    Full Text »    PDF »
From the Cover: Phenotypic correction of murine hemophilia A using an iPS cell-based therapy.
D. Xu, Z. Alipio, L. M. Fink, D. M. Adcock, J. Yang, D. C. Ward, and Y. Ma (2009)
PNAS 106, 808-813
   Abstract »    Full Text »    PDF »
Reprogramming of murine and human somatic cells using a single polycistronic vector.
B. W. Carey, S. Markoulaki, J. Hanna, K. Saha, Q. Gao, M. Mitalipova, and R. Jaenisch (2009)
PNAS 106, 157-162
   Abstract »    Full Text »    PDF »
Nuclear Reprogramming in Cells.
J. B. Gurdon and D. A. Melton (2008)
Science 322, 1811-1815
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)